 |
Articles: Drug Approvals |
Prior Articles
Abbott Announces Approval in China for Next-Generation XIENCE V Drug Eluting Stent
Abbott, 09/15/09
Trabectedin: an anticancer drug from the sea
Expert Opinion in Pharmacotherapy, 09/14/09 Financing of U.S. Biomedical Research and New Drug Approvals across Therapeutic Areas
PLoS ONE - Cardiovascular Disorders, 09/14/09 CryoLife Announces First Clinical Use of BioFoam
Cryolife, 09/11/09
Free full text
Astellas receives FDA approval for use of progr (tacrolimus) in conjunction with mycophenolate mofetil (mmf) in kidney transplant recipients
Astellas, 09/11/09
Free full text
Synthon announces European approvals for generic Rivastigmine
Synthon, 09/11/09
Free full text
Par Pharmaceutical Receives Final Approval To Market Generic Starlix
Par Pharmaceutical, 09/11/09 Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/10/09
Free full text
FDA Advisory Committee Recommends Approval for Use of GARDASIL in Boys and Men
Merck & Co., 09/10/09
Free full text
Electronic Safety Reporting May Soon Be Mandatory, says FDA
Pharmaceutical Technology, 09/09/09
Free full text
Novel evidence-based systemic lupus erythematosus (sle) responder index described in peer reviewed publication as potentially significant advance in lupus drug development
Human Genome Sciences, 09/08/09
Free full text
Takeda Receives FDA Complete Response Letter for the Investigational Fixed-Dose Combination of alogliptin and ACTOSÂ for the Treatment of Type 2 Diabetes
Takeda Pharmaceuticals North America, 09/08/09 AstraZeneca announces FDA acceptance of New Drug Application for VIMOVO
AstraZeneca, 09/04/09
Free full text
MabThera approved in Europe for use in patients with previously-treated chronic lymphocytic leukaemia
Roche, 09/04/09
Free full text
Bristol-Myers Squibb Announces Acceptance of Submission for Belatacept Biologic License Application
Bristol Myers-Squibb Company, 09/04/09
Free full text
FDA Accepts to File Cell Therapeutics New Drug Application for Pixantrone
Cell Therapeutics, 09/04/09
Free full text
Acura Pharmaceuticals and King Pharmaceuticals Provide Update on ACUROX® NDA
King Pharmaceuticals, 09/04/09
Free full text
Shire Announces FDA Approval of Once-Daily INTUNIV? (guanfacine) Extended Release Tablets for the Treatment of ADHD in Children and Adolescents Aged 6 to 17
Shire, 09/04/09 U.S. physician knowledge of the FDA-approved indications and evidence base for commonly prescribed drugs: results of a national survey
Pharmacoepidemiology and Drug Safety, 09/02/09 FDA Approves Valcyte (valganciclovir hydrochloride) to Prevent Cytomegalovirus (CMV) Disease in Pediatric Patients Who Receive Heart or Kidney Transplants
Roche, 09/02/09
Free full text
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Expert Opinion in Pharmacotherapy, Formulary, U.S.Pharmacist
more...
|
166 Available Pages
|
|
